短暂与持续性血小板减少症危重患者的院内死亡风险:一项回顾性研究
该回顾性研究纳入2010年1月至2020年12月首次入住ICU的3291例患者,按血小板减少持续时间分为无血小板减少、1-2天、3-6天和≥7天组,并用MIMIC-III数据集进行外部验证。结果显示37.3%的患者在ICU期间发生血小板减少,持续时间越长输血量越大、院内死亡率越高(P<0.01)。排除ICU入住后短期内死亡患者后,Kaplan-Meier生存分析和Cox回归显示无血小板减少组与1-2天组无显著差异(P>0.05),但持续时间超过2天后死亡率随时长增加(P<0.01),MIMIC-III数据得到相似结果。作者以2天为界将血小板减少分为短暂性和持续性,认为监测持续时间有助于预测ICU患者预后。
要点
- 3291例首次入住ICU患者中37.3%发生血小板减少,持续时间越长输血量越大、院内死亡率越高(P<0.01)。
- 排除ICU入住后短期死亡者后,无血小板减少组与血小板减少1-2天组生存无显著差异(P>0.05)。
- 血小板减少持续超过2天后,患者死亡率随持续时间延长而增加(P<0.01),MIMIC-III数据结果相似。
- 作者以2天为界将血小板减少分为短暂性和持续性,认为监测持续时间有助于预测ICU患者预后。
适用人群与场景
- 2010年1月至2020年12月首次入住ICU的3291例患者,按血小板减少持续时间分为无血小板减少、1-2天、3-6天和≥7天组。
- 外部验证使用MIMIC-III数据集。
诊断标准与关键阈值
- 作者以血小板减少持续2天为界,分为短暂性血小板减少(≤2天)和持续性血小板减少(>2天)。
研究设计与关键结果
- 回顾性研究,纳入3291例首次入住ICU患者,按血小板减少持续时间分组,并用MIMIC-III数据集外部验证。
- 37.3%的患者在ICU期间发生血小板减少;血小板减少持续时间越长,输血量越大、院内死亡率越高(P<0.01)。
- 排除ICU入住后短期内死亡患者后,Kaplan-Meier生存分析和Cox回归显示无血小板减少组与血小板减少1-2天组无显著差异(P>0.05)。
- 血小板减少持续时间超过2天后,患者死亡率随持续时间延长而增加(P<0.01);MIMIC-III数据集得到相似结果。
证据类型、等级与局限
- 证据类型:回顾性研究,使用MIMIC-III数据集进行外部验证。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,监测血小板减少的持续时间可能有助于预测ICU患者的预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Thrombocytopenia (TP), a common occurrence among patients admitted to the intensive care unit (ICU), is significantly associated with prolonged ventilator use, prolonged ICU stay, and increased mortality. The duration of TP serves as an indicator of patient outcome, although the exact duration of TP associated with poor patient outcome remains unclear. In this study, the data of 3,291 patients on their first admission to the ICU between January 2010 and December 2020 were retrospectively analyzed. Participants were divided into the no TP, TP 1-2 days, TP 3-6 days, and TP ≥7 days groups based on the duration of TP. External validation was performed using the Medical Information Mart for Intensive Care III data set. Results: A longer duration of TP was significantly associated with high volume of transfusion and high hospital mortality ( P < 0.01), and 37.3% of the participants developed TP during their ICU stay. The results of Kaplan-Meier survival analysis and Cox regression analysis after excluding the effects of patients who died shortly after ICU admission revealed the absence of significant differences between the no TP and TP 1-2 days groups ( P > 0.05). However, when the duration of TP exceeded 2 days, patient mortality increased with an increase in the duration of TP ( P < 0.01). Similar findings were obtained with the Medical Information Mart for Intensive Care III data set. Conclusions: The duration of TP in critically ill patients is positively correlated with poor patient outcome. We classified TP as either transient TP or persistent TP based on a cutoff duration of 2 days. Monitoring the duration of TP may aid in the prediction of patients' outcome in the ICU.
参考来源
- Jiang X, Zhang W, Ma X, et al. RISK OF HOSPITAL MORTALITY IN CRITICALLY ILL PATIENTS WITH TRANSIENT AND PERSISTENT THROMBOCYTOPENIA: A RETROSPECTIVE STUDY. Shock. 2022. PMID: 36516455. doi:10.1097/SHK.0000000000002005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。